Hepatoprotective and antioxidant activity of N-acetyl cysteine in carbamazepine-administered rats

Indian Journal of Pharmacology

Volumn 46, Issue 2, 2014, Pages 211-215

  Maheswari, Eswaran ^a   Saraswathy, Ganesan Raja Lekshmi ^a   Santhranii, Thakur ^b  

^a RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES   (India)

^b INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

Author keywords

Carbamazepine; hepatotoxicity; N acetyl cysteine; oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBAMAZEPINE; GLUTATHIONE; LIVER PROTECTIVE AGENT; PROTEIN; ANTICONVULSIVE AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DEGENERATION; DRUG EFFECT; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER CENTRILOBULAR CONGESTION; LIVER CONGESTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER LEVEL; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; LIVER VACUOLAR DEGENERATION; LIVER WEIGHT; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; DOSE RESPONSE; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; TOXICITY; WISTAR RAT;

ACETYLCYSTEINE; ANIMALS; ANTICONVULSANTS; ANTIOXIDANTS; BODY WEIGHT; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; LIPID PEROXIDATION; LIVER; LIVER FUNCTION TESTS; MALE; ORGAN SIZE; RATS, WISTAR;

EID: 84897497566     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.129321     Document Type: Article

References (31)

1. Wyllie E, Wyllie R. Routine laboratory monitoring for serious adverse effects of antiepileptic medications: The controversy. Epilepsia 1991;32:S74-9
2. Bernus I, Dickinson RG, Hooper WD, Eadie MJ. Dose-dependent metabolism of carbamazepine in humans. Epilepsy Res 1996;24:163-72
3. Scheyer RD, Cramer JA, Mattson RH. A pharmacodynamic approach to the estimate of carbamazepine autoinduction. J Pharm Sci 1994;83:491-4
4. Benedetti MS, Ruty B, Baltes E. Induction of endogenous pathways by antiepileptics and clinical implications. Fundam Clin Pharmacol 2005;19:511-29
5. Driefus FE, Langer DH. Hepatic considerations in the use of antiepileptic drugs. Epilepsia 1987;28:S23-9
6. Hopen G, Nesthus I, Laerum OD. Fatal CBZ-Associated hepatitis. Report of two cases. Acta Med Scand 1981;210:333-5
7. Zucker P, Daum F, Cohen MI. Fatal carbamazepine hepatitis. J Pediatr 1977;91:667-8
8. Pellock JM. Carbamazepine side effects in children and adults. Epilepsia 1987;28:S64-70
9. Mitchell MC, Boitnott JK, Arregui A, Maddrey WC. Granulomatous hepatitis associated with carbamazepine therapy. Am J Med 1981;71:733-5
10. Havel RJ, Kane JP. Structure and metabolism of plasma lipoproteins. In: Secriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 1995. p. 1841-51
11. Santos NA, Medina WS, Martins NM, Mingatto FE, Curti C, Santos AC. Aromatic antiepileptic drugs and mitochondrial toxicity: Effects on mitochondria isolated from rat liver. Toxicol In Vitro 2008;22:1143-52
12. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007;48:1223-44
13. Horowitz S, Patwardhan R, Marcus E. Hepatotoxic reactions associated with carbamazepine therapy. Epilepsia 1988;29:149-54
14. Bavdekar SB, Muranjan MN, Gogtay NJ, Kantharia V, Kshirsagar NA. Anticonvulsant hypersensitivity syndrome: Lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment. Ann Pharmacother 2004;38:1648-50
15. Kass GE. Mitochondrial involvement in drug-induced hepatic injury. Chem Biol Interact 2006;163:145-59
16. Nitti M, Pronzato MA, Marinari UM, Domenicotti C. PKC signaling in oxidative hepatic damage. Mol Aspects Med 2008;29:36-42
17. Sedlak J, Lindsay RH. Estimation of total, protein bound and non-protein SH groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205
18. Mihara M, Uchiyama M. Determination of malonaldehyde precursors in tissues by thiobarbituric acid test. Ann Biochem 1978;86:271-8
19. Li Y, Powers C, Jiang N, Chopp M. Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat. J Neurol Sci 1998;156:119-32
20. Eghbal MA, Taziki S, Sattari MR. Protective role of melatonin and taurine against carbamazepine-induced toxicity in freshly isolated rat hepatocytes. Int J Morphol 2013;1:1081-9
21. Adikwu E, Deo O. Hepatoprotective Effect of Vitamin C (Ascorbic Acid). Pharmacol Pharm 2013;4:84-92
22. Santhrani T, Maheswari E, Saraswathy GR. Carbamazepine provoked hepatotoxicity: Attenuation by vitamin C. Oxid Antioxid Med Sci 2013;2:37-43
23. Salehi M, Jafari M, Asgari A. The protective effect of N-Acetyl-Cysteine on DZN-induced hepatotoxicity. Clin Biochem 2011;44:S123
24. Manov I, Hirsh M, Iancu TC. Acetaminophen hepatotoxicity and mechanisms of its protection by N-Acetylcysteine: A study of Hep3B cells. Exp Toxicol Pathol 2002;53:489-500
25. Valles EG, de Castro CR, Castro JA. N-Acetyl cysteine is an early but also a late preventive agent against carbon tetrachloride-induced liver necrosis. Toxicol Lett 1994;71:87-95
26. Ronis MJ, Butura A, Sampey BP, Shankar K, Prior RL, Korourian S, et al. Effects of N-Acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic Biol Med 2005;39:619-30
27. Ioannides C, Hall DE, Mulder DE, Steele CM, Spickett J, Delaforge M, et al. A comparison of the protective effects of N-Acetylcysteine and S-carboxymethylcysteine against paracetamol-induced hepatotoxicity. Toxicology 1983;28:313-21
28. Wong CK, Ooi VE, Wong CK. Protective effects of N-Acetylcysteine against carbon tetrachloride and trichloroethylene induced poisoning in rats. Environ Toxicol Pharmacol 2003;14:109-16
29. Menor C, Cara CJ, Fernandez-Moreno MD, Fueyo JA, Escribano O, Olleros T, et al. Protective role and molecular basis of N-Acetyl-L-cysteine usage in azathioprine-induced rat hepatocyte necrosis. Gastroenterology 2003;124:A723
30. Raza M, Ahmad M, Gado A, Al-Shabanah OA. A comparison of hepatoprotective activities of aminoguanidine and N-Acetylcysteine in rat against the toxic damage induced by azathioprine. Comp Biochem Physiol C Toxicol Pharmacol 2003;134:451-6
31. Chen CF, Hsueh CW, Tang TS, Wang D, Shen CY, Pei JS. Reperfusion liver injury-induced superoxide dismutase and catalase expressions and the protective effects of N-Acetyl cysteine. Transplant Proc 2007;39:858-60